HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A clinical trial of removal of bilirubin in blood by Evaflux-2A.

Abstract
We performed both free and albumin-bound bilirubin removal therapy using the Evaflux-2A and evaluated its clinical effects. The removal rates of total bilirubin in the first and second sessions were 31.4%, and 31.0%, respectively. Our clinical data suggested that plasma exchange using Evaflux-2A and an albumin-added electrolyte solution as the substitute fluid was useful in the treatment of hyperbilirubinemia.
AuthorsM Hida, T Takamiya, N Kitajima, S Hiraga, T Satoh
JournalThe Tokai journal of experimental and clinical medicine (Tokai J Exp Clin Med) Vol. 11 Issue 5 Pg. 335-8 (Nov 1986) ISSN: 0385-0005 [Print] Japan
PMID3672561 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Macromolecular Substances
  • Polyvinyls
  • ethylene-vinyl alcohol copolymer
  • Bilirubin
Topics
  • Bilirubin (blood)
  • Hemofiltration (methods)
  • Humans
  • Hyperbilirubinemia (blood, therapy)
  • Macromolecular Substances
  • Male
  • Middle Aged
  • Plasma Exchange (instrumentation)
  • Polyvinyls (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: